학술논문

Real-world experience of switching from intravenous to subcutaneous vedolizumab maintenance treatment for inflammatory bowel diseases
Document Type
Article
Source
In: Alimentary Pharmacology and Therapeutics. (Alimentary Pharmacology and Therapeutics, September 2022, 56(6):1044-1054)
Subject
Language
English
ISSN
13652036
02692813